Clinical Features and Diagnosis of Cardiac Sarcoidosis

Claudio Tana1, Cesare Mantini2, Iginio Donatiello3

  • 1COVID-19 Medicine Unit and Geriatrics Clinic, SS Annunziata Hospital of Chieti, 66100 Chieti, Italy.

Insights

Cardiac sarcoidosis (CS) is a serious manifestation of systemic sarcoidosis. Advanced imaging like CMR and 18F-FDG PET offers a cost-effective diagnostic approach, potentially replacing invasive biopsies.

Area of Science:

  • Cardiology
  • Pulmonology
  • Immunology

Background:

  • Cardiac sarcoidosis (CS) is an uncommon yet severe manifestation of systemic sarcoidosis (SA).
  • While lungs are typically affected, CS can impact up to 25% of SA patients, often leading to poor prognosis and mortality, especially in African American individuals.
  • Non-specific symptoms of CS can mimic other cardiac disorders, complicating diagnosis.

Purpose of the Study:

  • To summarize the clinical features and diagnostic imaging findings of cardiac sarcoidosis.
  • To highlight the role of cardiovascular magnetic resonance (CMR) and 18-Fluorodeoxyglucose Positron Emission Tomography (18F-FDG PET) in diagnosing CS.
  • To evaluate the cost-benefit ratio of imaging modalities for CS diagnosis.

Main Methods:

  • This narrative review synthesizes current literature on cardiac sarcoidosis.
  • Focuses on clinical presentations and diagnostic imaging techniques, specifically CMR and 18F-FDG PET.
  • Compares the diagnostic utility and risks of imaging versus endomyocardial biopsy.

Main Results:

  • Cardiac involvement in sarcoidosis is associated with significant morbidity and mortality.
  • CMR and 18F-FDG PET provide valuable insights into CS diagnosis with a favorable cost-benefit ratio.
  • Imaging techniques can accurately detect cardiac involvement, guiding treatment decisions.

Conclusions:

  • Cardiac sarcoidosis diagnosis is challenging due to non-specific symptoms.
  • CMR and 18F-FDG PET are crucial non-invasive tools for diagnosing CS.
  • Advanced imaging can reduce the need for invasive procedures like endomyocardial biopsy, improving patient safety.

Related Concept Videos

Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
101
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
70
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
145
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
110
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
178
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
61